$ANI Pharmaceuticals (ANIP.US)$Revenue has been continuously...

逍遥投资派 commented on a stock · May 20, 2023 22:59

$ANI Pharmaceuticals (ANIP.US)$Revenue has been continuously increasing in the past 5 years, especially a surge of 46.4% in 2022. However, operating profit has been consistently declining. It entered a loss range in 2020, worsened in 2021, and the loss narrowed by 8.6% in 2022. Meanwhile, net income has been continuously expanding since 2020.

Revenue surged by 65.6% in Q1 2023. Both operating profit and net income turned losses around. Looking at the quarterly report on a quarter-on-quarter basis, revenue and profits have been continuously growing over the past 5 months, which is a good sign of turning losses around.

Currently, there is only profit data for one month. It is advisable to wait for several more quarterly reports before making a decision.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

5220 Views

Comment

逍遥投资派

588

Followers

Following

3217

Visitors